Navicular Syndrome and Podotrochloosis

Navicular syndrome, also known as podotrochloosis, is a chronic, progressive, and often debilitating lameness condition affecting the podotrochlear apparatus of the equine forelimb, primarily involving the navicular bone, the navicular bursa, the deep digital flexor tendon (DDFT), and the associated collateral sesamoidean ligaments. The condition is characterized by pain localized to the caudal half of the foot, typically exacerbated by work on hard surfaces or downhill exercise, and is a leading cause of chronic forelimb lameness in performance horses, particularly Quarter Horses, Thoroughbreds, and Warmbloods. Podotrochloosis encompasses a spectrum of pathological changes including flexor cortical bone sclerosis, medullary sclerosis, cyst-like lesions, vascular compromise, and degenerative changes in the fibrocartilage and adjacent soft tissues. The disease is multifactorial, with biomechanical overload, conformation, and possibly vascular insufficiency contributing to its pathogenesis. Navicular syndrome is a significant economic and welfare concern in the equine industry, often leading to premature retirement from athletic activity. The condition is diagnosed through a combination of clinical examination, regional anesthesia, and advanced imaging modalities such as MRI and CT, which have revolutionized our understanding of the disease by revealing soft tissue and osseous lesions not visible on conventional radiography. Treatment is aimed at pain management, biomechanical correction through therapeutic farriery, and in some cases, surgical intervention such as palmar digital neurectomy, though the latter is reserved for refractory cases due to potential complications. Prognosis for return to athletic function is guarded to fair, depending on the severity and chronicity of the lesions, with many horses becoming pasture sound or able to perform at lower levels.

The exact etiology of navicular syndrome is not fully understood, but it is widely accepted to be multifactorial, involving a combination of biomechanical, conformational, vascular, and possibly genetic factors. Biomechanical overload is considered a primary inciting cause, particularly in horses with upright pastern conformation, small feet relative to body size, or sheared heels, which increase the load on the navicular bone and its associated structures. The navicular bone acts as a fulcrum for the deep digital flexor tendon (DDFT), and during weight-bearing, the DDFT exerts significant compressive and frictional forces on the flexor surface of the bone. Repetitive high-impact exercise, especially on hard surfaces, can lead to microdamage and subsequent remodeling of the navicular bone, resulting in sclerosis, cyst formation, and enthesophyte development. Vascular compromise has also been proposed as a contributing factor, with theories suggesting that increased pressure within the navicular bone during weight-bearing leads to ischemia and subsequent bone necrosis, although this theory has been debated. Additionally, chronic inflammation of the navicular bursa and DDFT, often secondary to repetitive trauma, can lead to adhesions and further degeneration. Genetic predisposition is suspected, as certain breeds and families have a higher incidence, but specific genes have not been identified. Other potential contributing factors include poor hoof balance, improper shoeing, and excessive toe length, which alter the biomechanics of the foot and increase stress on the podotrochlear apparatus. In some cases, navicular syndrome may be secondary to other conditions such as laminitis or distal interphalangeal joint disease, which can alter foot mechanics and predispose to navicular pathology.

Navicular syndrome is one of the most common causes of chronic forelimb lameness in performance horses, with a reported prevalence ranging from 10% to 30% in certain equine populations. It is most frequently diagnosed in middle-aged horses (between 4 and 15 years old), with a mean age of onset around 7 to 9 years. The condition is more common in geldings and stallions than in mares, possibly due to differences in body weight and conformation. Certain breeds are overrepresented, including Quarter Horses, Thoroughbreds, Warmbloods, and Arabian horses, while ponies and draft breeds are less commonly affected. The disease is primarily seen in horses used for disciplines that require repetitive high-speed work or jumping, such as barrel racing, cutting, reining, eventing, and show jumping, but it can also occur in pleasure and trail horses. There is no strong seasonal predilection, but lameness may worsen in colder months due to increased hoof hardness and reduced shock absorption. Housing and management factors, such as prolonged stall confinement with limited turnout, may contribute to the development of the condition due to reduced hoof circulation and increased weight-bearing on hard surfaces. Diet does not appear to play a direct role, but obesity and metabolic syndrome may exacerbate the condition by increasing mechanical load. The morbidity is high in affected populations, with many horses experiencing recurrent or persistent lameness that limits their athletic career. Mortality is negligible, but the economic impact is substantial due to veterinary costs, loss of use, and premature retirement. The condition is often bilateral, with both forelimbs affected, although one limb may be more severely affected than the other.

The pathophysiology of navicular syndrome involves a complex interplay of biomechanical stress, vascular changes, and degenerative processes within the podotrochlear apparatus. The navicular bone is a small, boat-shaped bone located palmar to the distal interphalangeal (DIP) joint, and it serves to maintain the angle of the deep digital flexor tendon (DDFT) as it inserts on the distal phalanx. During weight-bearing, the DDFT exerts a compressive force on the flexor surface of the navicular bone, and the bone also experiences tension from the collateral sesamoidean ligaments and the distal sesamoidean impar ligament. Repetitive loading, especially in horses with poor conformation or improper shoeing, leads to microdamage of the subchondral bone and fibrocartilage. The bone responds by remodeling, initially with increased bone density (sclerosis) in the flexor cortex, which can progress to medullary sclerosis and eventually to cyst-like lesions as the bone attempts to repair. Vascular compromise is thought to play a role, as the navicular bone has a limited blood supply, and increased intraosseous pressure during weight-bearing may lead to ischemia and subsequent bone necrosis. This is supported by histopathological findings of avascular areas and fibrosis in affected bones. The navicular bursa, which lies between the DDFT and the navicular bone, can become inflamed (bursitis) due to friction and pressure, leading to synovial proliferation and adhesions. The DDFT itself may undergo degenerative changes, including fibrillation, tearing, and calcification, particularly at its insertion on the distal phalanx. These changes are often visible on MRI as increased signal intensity on T2-weighted images. The collateral sesamoidean ligaments and the distal sesamoidean impar ligament can also be affected, with desmitis and enthesophyte formation at their attachments. The pain associated with navicular syndrome is likely due to a combination of bone pain (from increased intraosseous pressure and microfractures), inflammation of the bursa and soft tissues, and neuropathic changes. The disease is progressive, with early lesions potentially reversible if managed appropriately, but advanced cases often have irreversible structural changes.

Several intrinsic and extrinsic factors predispose horses to navicular syndrome. Intrinsic factors include conformation, age, breed, and sex. Horses with upright pasterns, small feet relative to body size, sheared heels, or a broken-back hoof-pastern axis are at increased risk due to altered biomechanics that increase load on the navicular bone. A narrow, contracted heel and underrun heels are also common conformational faults associated with the condition. Age is a significant factor, with the disease most commonly diagnosed in middle-aged horses, as cumulative wear and tear over time leads to degenerative changes. Breed predisposition is evident, with Quarter Horses, Thoroughbreds, and Warmbloods being overrepresented, likely due to their use in high-impact disciplines. Geldings and stallions are more commonly affected than mares, possibly due to larger body mass and more intense training. Extrinsic factors include management and exercise practices. Horses that are confined to stalls for prolonged periods with limited turnout may have reduced hoof circulation and increased weight-bearing on hard surfaces, predisposing to the condition. High-intensity exercise on hard or uneven surfaces, especially in disciplines like jumping, barrel racing, and cutting, increases the risk. Improper farriery, such as excessive toe length, inadequate heel support, or infrequent trimming, can exacerbate biomechanical stress. Sudden changes in exercise intensity or footing can also trigger the onset of clinical signs. Additionally, obesity and metabolic conditions such as equine metabolic syndrome (EMS) may increase the risk due to increased mechanical load and systemic inflammation. Poor hoof care, including neglect of routine trimming and shoeing, is a major modifiable risk factor. Finally, a history of previous foot trauma or other lameness conditions may predispose to navicular syndrome by altering gait and weight distribution.

The clinical signs of navicular syndrome are characterized by a chronic, progressive lameness that is often bilateral, though one limb may be more severely affected. The lameness is typically worse on hard surfaces, on a circle (especially with the affected limb on the inside), and when going downhill. Horses may show a shortened stride, landing toe-first to avoid heel pressure, and a 'pottery' or 'stumbling' gait. At rest, the horse may point the affected foot (resting the toe) to relieve pressure on the heel. When both forelimbs are affected, the horse may stand with the forelimbs extended forward, shifting weight to the hindlimbs. On physical examination, there may be a positive response to hoof testers applied over the middle third of the frog, and digital pulse amplitude may be increased in the affected limb(s). The lameness can be graded using the AAEP lameness scale (0-5), with grades typically ranging from 2 to 4. In early cases, the lameness may be subtle and only apparent at the trot on a hard surface or when lunged on a circle. As the disease progresses, the lameness becomes more consistent and may be present at a walk. There may be muscle atrophy in the shoulder and pectoral region due to chronic pain and disuse. The horse may also show signs of pain when the hoof is flexed or when pressure is applied to the heel region. In advanced cases, there may be visible hoof changes such as contracted heels, a narrow frog, and a concave sole. The lameness is often exacerbated by distal limb flexion tests, such as the distal interphalangeal joint flexion test, which increases pressure on the navicular region. It is important to note that clinical signs can vary depending on the specific structures involved, and some horses may have significant radiographic changes without clinical lameness, while others may have severe lameness with minimal radiographic findings.

The differential diagnoses for navicular syndrome include several other causes of foot lameness that must be ruled out through diagnostic testing. These include: 1) Deep digital flexor tendon (DDFT) tendinopathy within the hoof capsule, which can occur independently or concurrently with navicular syndrome; MRI is often needed to differentiate. 2) Distal interphalangeal (DIP) joint osteoarthritis (ringbone), which is characterized by pain on DIP joint flexion and radiographic evidence of periarticular new bone and joint space narrowing. 3) Laminitis, which typically presents with acute severe lameness, increased digital pulses, and characteristic radiographic changes such as rotation of the distal phalanx. 4) Puncture wounds or abscesses of the foot, which cause acute lameness and are diagnosed by hoof testers, paring, and possibly radiography or MRI. 5) Fractures of the navicular bone or distal phalanx, which are usually acute and diagnosed by radiography or MRI. 6) Collateral ligament desmitis of the DIP joint, which causes lameness localized to the foot and is diagnosed by MRI or ultrasound. 7) Podotrochlear bursitis, which may be primary or secondary to navicular syndrome and is characterized by distension of the bursa and pain on pressure over the frog. 8) Osseous cyst-like lesions in the distal phalanx or navicular bone, which can cause lameness and are identified on radiography or MRI. 9) Septic arthritis or osteomyelitis of the DIP joint, which is usually acute and associated with systemic signs. 10) Chronic proliferative pododermatitis (canker), which is a rare condition affecting the frog and sole. Each differential can be ruled out based on specific clinical features, response to regional anesthesia, and imaging findings. For example, DDFT tendinopathy may show focal swelling and pain on palpation of the tendon within the hoof, and MRI reveals increased signal intensity. DIP joint osteoarthritis is confirmed by intra-articular anesthesia of the DIP joint and radiographic changes. Laminitis is differentiated by the presence of divergent sole rings, increased digital pulses, and radiographic evidence of distal phalanx rotation. Abscesses are identified by paring the sole and finding a tract, and radiography may show a gas pocket. Fractures are visible on radiography or MRI. Collateral ligament desmitis is diagnosed by MRI or ultrasound. Podotrochlear bursitis is confirmed by contrast radiography or MRI. Osseous cyst-like lesions are seen on radiography or MRI. Septic arthritis is diagnosed by synovial fluid analysis and culture. Canker is identified by its characteristic proliferative, cauliflower-like appearance.

The diagnostic algorithm for navicular syndrome follows a systematic approach to confirm the diagnosis and rule out other causes of foot lameness. The first step is a thorough history and physical examination, including observation of the horse at rest and in motion (at the walk and trot, on a straight line and on a circle, on hard and soft surfaces). The horse is assessed for lameness using the AAEP grading scale, and any gait abnormalities are noted. Next, a complete hoof examination is performed, including inspection of hoof shape, balance, and shoeing, palpation of the digital pulses, and application of hoof testers to identify painful areas, particularly over the frog and heel region. A distal limb flexion test (e.g., DIP joint flexion) is performed to exacerbate lameness. If lameness is localized to the foot, regional anesthesia is performed in a stepwise manner. The first block is the palmar digital nerve block (at the level of the proximal phalanx), which desensitizes the caudal half of the foot, including the navicular region. If the lameness resolves, the pain is likely in the palmar foot. If not, an abaxial sesamoid nerve block is performed to desensitize the entire foot. If the lameness persists, the source is likely proximal to the foot. Once the pain is localized to the palmar foot, further diagnostic imaging is indicated. Radiography of the foot is the initial imaging modality, with views including lateromedial, dorsopalmar, and oblique projections. Radiographic changes associated with navicular syndrome include enlargement of the navicular bone, flexor cortical sclerosis, medullary sclerosis, cyst-like lesions, and enthesophytes on the proximal and distal borders. However, radiography has limitations, as many horses with navicular syndrome have minimal or no radiographic changes. Therefore, advanced imaging is often necessary. Ultrasonography can be used to evaluate the DDFT and navicular bursa through the frog, but it is limited by the hoof capsule. MRI is the gold standard for diagnosing navicular syndrome, as it provides detailed images of the navicular bone, DDFT, bursa, and ligaments, and can identify soft tissue and osseous lesions not visible on radiography. CT is also useful for evaluating osseous changes, particularly in the navicular bone. Scintigraphy (bone scan) can identify areas of increased bone remodeling, but it is less specific. In some cases, diagnostic anesthesia of the navicular bursa or DIP joint may be performed to further localize the pain. The diagnostic algorithm is complete when a definitive diagnosis is made and other differentials are ruled out.

Laboratory findings in navicular syndrome are generally nonspecific, as the condition is primarily a mechanical and degenerative disease rather than a systemic inflammatory or infectious process. However, certain laboratory tests may be performed to rule out other conditions or to assess for concurrent metabolic issues. A complete blood count (CBC) is typically within normal limits, although a mild stress leukogram (neutrophilia, lymphopenia) may be present due to chronic pain. Serum biochemistry may reveal mild elevations in muscle enzymes (creatine kinase, CK, and aspartate aminotransferase, AST) if there is muscle atrophy or myopathy secondary to altered gait, but these are usually within normal limits. In horses with suspected metabolic syndrome, baseline insulin and glucose levels, as well as an oral sugar test (OST) or combined glucose-insulin tolerance test (CGIT), may be performed to assess insulin dysregulation. Serum amyloid A (SAA) is a marker of acute inflammation and is typically normal in navicular syndrome, unless there is a concurrent infection. Synovial fluid analysis from the DIP joint or navicular bursa may be performed if septic arthritis or bursitis is suspected; in navicular syndrome, the fluid is usually normal or shows mild, non-inflammatory changes (e.g., slightly increased protein and cell count). Peritoneal fluid analysis is not relevant to this condition. In cases where a systemic inflammatory or infectious cause is suspected, additional tests such as bacterial culture and sensitivity of synovial fluid or blood cultures may be indicated. Overall, laboratory findings are not diagnostic for navicular syndrome, and the diagnosis relies primarily on imaging and response to regional anesthesia.

Imaging plays a crucial role in the diagnosis and management of navicular syndrome. Radiography is the first-line imaging modality and includes a standard foot series: lateromedial (LM), dorsopalmar (DP), and oblique views. On the LM view, the navicular bone is evaluated for changes in shape, size, and radiopacity. Common radiographic findings include: enlargement of the navicular bone, flexor cortical sclerosis (increased radiopacity of the flexor cortex), medullary sclerosis (increased radiopacity of the medullary cavity), cyst-like lesions (well-defined radiolucencies), and enthesophytes on the proximal and distal borders (new bone formation at ligament attachments). The DP view is useful for assessing the distal border of the navicular bone, where distal border fragments or cysts may be seen. Radiographic changes are graded using a scale (e.g., 0-4) based on severity, but it is important to note that radiographic changes do not always correlate with clinical lameness. Ultrasonography can be performed through the frog to evaluate the DDFT and navicular bursa, but it is limited by the hoof capsule and requires specialized equipment and expertise. It can identify DDFT lesions, bursal distension, and adhesions. Scintigraphy (bone scan) is a nuclear imaging technique that detects areas of increased bone remodeling; in navicular syndrome, there is typically increased uptake in the navicular bone, but this is nonspecific. Computed tomography (CT) provides high-resolution images of the osseous structures and is excellent for detecting subtle changes in the navicular bone, such as cysts, fractures, and sclerosis. Magnetic resonance imaging (MRI) is the gold standard for diagnosing navicular syndrome, as it provides detailed images of both osseous and soft tissue structures. MRI can identify lesions in the DDFT (e.g., core lesions, tears, degeneration), navicular bursa (e.g., inflammation, adhesions), collateral sesamoidean ligaments, distal sesamoidean impar ligament, and the navicular bone (e.g., bone marrow edema, cysts, sclerosis). MRI findings are often classified based on the location and severity of lesions, and they have been shown to correlate with prognosis. Advanced imaging is particularly valuable in cases where radiography is normal but clinical signs are strongly suggestive of navicular syndrome.

Cytology and histopathology are not commonly performed in the antemortem diagnosis of navicular syndrome, as the condition is primarily diagnosed through imaging and clinical examination. However, in cases where the navicular bursa is distended or there is suspicion of infection, synovial fluid may be aspirated from the navicular bursa for cytological analysis. Normal synovial fluid is clear, viscous, and has a low nucleated cell count (<500 cells/µL) and total protein (<2.5 g/dL). In navicular syndrome, the fluid may be slightly turbid with an increased cell count (up to 5,000 cells/µL) and protein (up to 4 g/dL), consistent with mild inflammation. The differential cell count typically shows a predominance of mononuclear cells, with few neutrophils. If septic bursitis is present, the fluid will be turbid, with a high nucleated cell count (>30,000 cells/µL), predominantly neutrophils, and elevated protein (>4 g/dL), and bacteria may be seen on Gram stain. Histopathology is rarely performed antemortem, but postmortem examination of the navicular bone and associated soft tissues reveals characteristic changes, including: fibrillation and erosion of the fibrocartilage on the flexor surface, subchondral bone sclerosis, medullary fibrosis, cyst formation, vascular changes (e.g., intimal thickening, thrombosis), and degeneration of the DDFT with areas of chondroid metaplasia and calcification. These histopathological findings are consistent with a chronic degenerative process. In research settings, histopathology is used to validate imaging findings and to study the pathogenesis of the disease.

The treatment of navicular syndrome is multifaceted and aims to alleviate pain, improve biomechanics, and slow the progression of the disease. The primary goals are to return the horse to a comfortable level of function and to prevent further degeneration. Treatment options include medical management, therapeutic farriery, and surgical interventions. Medical management typically involves the use of non-steroidal anti-inflammatory drugs (NSAIDs) to control pain and inflammation. Phenylbutazone is commonly used at a dose of 2.2-4.4 mg/kg IV or PO q12-24h, but long-term use should be avoided due to potential gastrointestinal and renal side effects. Firocoxib, a COX-2 selective NSAID, is an alternative at a dose of 0.1 mg/kg PO q24h, which may have fewer side effects. Isoxsuprine hydrochloride, a vasodilator, has been used historically at a dose of 0.6-1.2 mg/kg PO q12h, but its efficacy is questionable. Pentoxifylline, a hemorheologic agent, has also been used at a dose of 8.4 mg/kg PO q12h to improve blood flow. Corticosteroids, such as triamcinolone acetonide or methylprednisolone acetate, may be injected into the navicular bursa or DIP joint to reduce inflammation, but repeated injections can be detrimental to cartilage and tendon health. Hyaluronan (hyaluronic acid) may be injected intra-articularly or intravenously to improve synovial fluid quality. Polysulfated glycosaminoglycan (PSGAG) can be given intramuscularly or intra-articularly to support cartilage health. Bisphosphonates, such as tiludronate and clodronate, have been used to modulate bone remodeling and reduce pain associated with navicular bone changes; tiludronate is given at a dose of 1 mg/kg IV once, and clodronate at 1.8 mg/kg IM once, but they should be used with caution in young horses. Therapeutic farriery is a cornerstone of treatment. The goal is to correct hoof balance and reduce pressure on the navicular region. This may involve trimming to achieve a normal hoof-pastern axis, providing heel support (e.g., egg-bar shoes, wedge pads), and using a rolled toe to facilitate breakover. A wide-web shoe with a rolled toe and a slightly raised heel can help redistribute forces. Regular farriery every 4-6 weeks is essential. Surgical options include palmar digital neurectomy, which involves cutting the palmar digital nerves to desensitize the heel region. This procedure can provide pain relief but is associated with complications such as neuroma formation, wound breakdown, and the risk of undetected injuries. It is generally reserved for horses that are unresponsive to medical management and are not intended for breeding. Other surgical procedures, such as navicular suspensory desmotomy, have been described but are not widely performed. Extracorporeal shockwave therapy (ESWT) has been used to treat navicular syndrome, with some studies showing improvement in lameness. Regenerative therapies, such as platelet-rich plasma (PRP) or stem cell therapy, are being investigated but are not yet standard of care. The treatment plan should be tailored to the individual horse, taking into account the severity of the disease, the intended use, and the owner's expectations.

The prognosis for navicular syndrome is variable and depends on several factors, including the severity and chronicity of the lesions, the specific structures involved, the response to treatment, and the intended use of the horse. In general, the prognosis for return to athletic function is guarded to fair. Horses with mild to moderate disease that respond well to medical management and therapeutic farriery may be able to return to some level of work, but may require ongoing management. Studies have shown that approximately 50-70% of horses with navicular syndrome can return to their previous level of activity with appropriate treatment, but many require a reduction in workload or a change in discipline. Horses with severe lesions, such as large cysts, deep DDFT tears, or significant bone remodeling, have a poorer prognosis. The presence of bilateral disease also worsens the prognosis. Negative prognostic indicators include: chronicity (more than 6 months), lack of response to initial treatment, severe lameness (grade 3 or higher), and the presence of multiple lesions on MRI. Horses that undergo palmar digital neurectomy may have a good short-term outcome, but the long-term prognosis is guarded due to potential complications and the risk of recurrence of lameness due to other causes. The prognosis for pasture soundness is generally good, with many horses becoming comfortable at rest or light work. It is important to set realistic expectations with the owner and to emphasize that navicular syndrome is a chronic condition that requires lifelong management. Regular follow-up and adjustments to farriery and medication are essential to maintain comfort and slow the progression of the disease.

Follow-up care for horses with navicular syndrome is essential to monitor the response to treatment and adjust the management plan as needed. Initially, horses should be re-evaluated 4-6 weeks after the start of treatment to assess the response to farriery and medication. The lameness should be re-graded using the AAEP scale, and the owner should be questioned about the horse's behavior and comfort level. If the horse has improved, the treatment plan may be continued, with gradual reintroduction of exercise. If there is no improvement, further diagnostic imaging (e.g., MRI) may be recommended to identify additional lesions. Serial radiographs may be taken every 6-12 months to monitor for progression of osseous changes, but it is important to note that radiographic changes may not correlate with clinical signs. For horses receiving bisphosphonates, follow-up blood work (e.g., renal parameters) may be recommended, as these drugs can affect renal function. Farriery should be performed every 4-6 weeks to maintain hoof balance and heel support. The horse's exercise program should be gradually increased, starting with hand-walking and progressing to trotting and cantering, depending on the severity of the disease and the response to treatment. It is important to avoid hard surfaces and high-impact activities until the horse is sound. The use of a hoof boot or pad may be beneficial during the initial rehabilitation period. Owners should be educated on the signs of worsening lameness and the importance of prompt veterinary attention. In cases where palmar digital neurectomy is performed, the surgical site should be monitored for complications such as infection, neuroma formation, or wound dehiscence. Long-term follow-up is recommended every 6-12 months to assess the horse's comfort and to make adjustments to the management plan as needed.

Clinical pearls for managing navicular syndrome include: 1) Always perform a thorough lameness examination, including flexion tests and regional anesthesia, to localize the source of pain before imaging. 2) Radiographs are not always diagnostic; many horses with navicular syndrome have normal radiographs, so advanced imaging (MRI) should be considered in cases with strong clinical suspicion. 3) Therapeutic farriery is the cornerstone of treatment; a well-balanced foot with heel support can significantly improve lameness. 4) NSAIDs should be used judiciously, as long-term use can lead to gastrointestinal ulcers and renal disease. 5) Bisphosphonates can be effective in reducing bone pain, but they should be used with caution in young horses and those with renal disease. 6) Palmar digital neurectomy should be considered a last resort, as it can lead to complications and may mask other foot problems. 7) Regular follow-up and owner education are essential for successful long-term management. Pitfalls to avoid include: 1) Failing to perform regional anesthesia before imaging, leading to misinterpretation of incidental findings. 2) Over-reliance on radiographs, which may miss soft tissue lesions. 3) Neglecting farriery, which can lead to progression of the disease. 4) Using corticosteroids in the navicular bursa repeatedly, which can cause tendon degeneration. 5) Recommending neurectomy too early, without exhausting medical management. 6) Ignoring the possibility of concurrent conditions, such as DDFT tendinopathy or DIP joint arthritis, which may require additional treatment. 7) Failing to monitor the horse's response to treatment and adjust the plan accordingly.

Current drug protocols for navicular syndrome are based on Plumb's Veterinary Drug Handbook and ACVIM guidelines. The following are commonly used medications with dosages and routes: 1) Phenylbutazone: 2.2-4.4 mg/kg IV or PO q12-24h, for short-term pain control (up to 5-7 days). 2) Flunixin meglumine: 1.1 mg/kg IV or PO q12-24h, for acute pain and inflammation. 3) Firocoxib: 0.1 mg/kg PO q24h, for long-term pain management with fewer GI side effects. 4) Isoxsuprine hydrochloride: 0.6-1.2 mg/kg PO q12h, historically used as a vasodilator, but efficacy is unproven. 5) Pentoxifylline: 8.4 mg/kg PO q12h, to improve blood flow and reduce inflammation. 6) Triamcinolone acetonide: 6-12 mg per navicular bursa or DIP joint, intra-articular or intrabursal, for anti-inflammatory effect; should be used sparingly. 7) Methylprednisolone acetate: 40-80 mg per joint, intra-articular, but less preferred due to potential cartilage damage. 8) Hyaluronan (hyaluronic acid): 20-40 mg intra-articular or 40 mg IV, to improve synovial fluid viscosity. 9) Polysulfated glycosaminoglycan (PSGAG): 500 mg IM q4-7 days for 4-6 weeks, or 250 mg intra-articular once weekly for 3 weeks. 10) Tiludronate: 1 mg/kg IV once, for bone remodeling; should be given with fluids to prevent renal toxicity. 11) Clodronate: 1.8 mg/kg IM once, for bone pain. 12) Omeprazole: 1-2 mg/kg PO q24h, to prevent NSAID-induced gastric ulcers. 13) Sucralfate: 20 mg/kg PO q8h, for gastric ulcer treatment. 14) Polymyxin B: 1000-2000 IU/kg IV q8-12h, for endotoxemia, but not typically used in navicular syndrome. 15) Antibiotics (e.g., penicillin G, gentamicin) are only indicated if there is a septic component. It is important to tailor the drug protocol to the individual horse, considering the severity of the disease, the presence of concurrent conditions, and the potential for side effects. Long-term use of NSAIDs should be avoided, and alternative pain management strategies should be explored.

The evidence-based literature on navicular syndrome is extensive, with numerous studies evaluating the diagnosis, treatment, and prognosis. Key landmark studies include: 1) A study by Dyson et al. (2005) using MRI to characterize lesions in horses with foot lameness, which identified a high prevalence of DDFT and navicular bone lesions, and demonstrated that MRI findings correlate with prognosis. 2) A study by Schramme et al. (2005) evaluating the use of tiludronate in the treatment of navicular syndrome, which showed significant improvement in lameness compared to placebo. 3) A study by Waguespack et al. (2011) comparing the efficacy of clodronate and tiludronate, which found both to be effective in reducing lameness. 4) A study by Bell et al. (2009) evaluating the long-term outcome of horses with navicular syndrome treated with therapeutic farriery, which reported that 60% of horses returned to some level of work. 5) A study by Gutierrez-Nibeyro et al. (2010) on the use of extracorporeal shockwave therapy, which showed improvement in lameness in some horses. 6) A study by Rijkenhuizen et al. (2008) on the outcome of palmar digital neurectomy, which reported good short-term results but a high rate of complications in the long term. 7) A consensus statement from the American College of Veterinary Internal Medicine (ACVIM) on the diagnosis and treatment of navicular syndrome, which provides evidence-based guidelines. 8) A meta-analysis by Dyson et al. (2011) on the diagnostic accuracy of radiography versus MRI, which concluded that MRI is superior for detecting soft tissue lesions. 9) A study by Sherlock et al. (2010) on the use of MRI to guide treatment, which showed that horses with DDFT lesions had a poorer prognosis than those with isolated navicular bone changes. 10) A study by Parkes et al. (2015) on the biomechanics of the navicular region, which provided insights into the pathogenesis of the disease. These studies highlight the importance of advanced imaging, the potential benefits of bisphosphonates, and the need for a multimodal approach to treatment. The overall evidence suggests that early diagnosis and aggressive management can improve the prognosis, but the disease remains a significant challenge in equine practice.